These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21303300)

  • 1. Biomarkers in Alzheimer's disease.
    Demarin V; Zavoreo I; Kes VB; Simundić AM
    Clin Chem Lab Med; 2011 May; 49(5):773-8. PubMed ID: 21303300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
    Thal DR; Attems J; Ewers M
    J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin in Alzheimer's disease.
    Magalhães CA; Carvalho MG; Sousa LP; Caramelli P; Gomes KB
    Clin Chim Acta; 2015 Oct; 450():162-8. PubMed ID: 26279362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease.
    Leoni V
    Clin Chem Lab Med; 2011 Mar; 49(3):375-83. PubMed ID: 21388338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apolipoprotein E4 and late-onset Alzheimer's disease].
    Tamaoka A
    Nihon Rinsho; 1994 Dec; 52(12):3257-65. PubMed ID: 7853720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
    Hansson O; Zetterberg H; Buchhave P; Londos E; Blennow K; Minthon L
    Lancet Neurol; 2006 Mar; 5(3):228-34. PubMed ID: 16488378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia.
    Ferrer I
    Prog Neurobiol; 2012 Apr; 97(1):38-51. PubMed ID: 22459297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vivo brain neuroimaging provides a gateway for integrating biological and clinical biomarkers of Alzheimer's disease.
    Cui J; Zufferey V; Kherif F
    Curr Opin Neurol; 2015 Aug; 28(4):351-7. PubMed ID: 26132531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in Sporadic and Familial Alzheimer's Disease.
    Lista S; O'Bryant SE; Blennow K; Dubois B; Hugon J; Zetterberg H; Hampel H
    J Alzheimers Dis; 2015; 47(2):291-317. PubMed ID: 26401553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
    Prvulovic D; Hampel H
    Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.
    Chételat G; Fouquet M
    Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Near a biological diagnosis of Alzheimer's disease and related disorders].
    Krolak-Salmon P; Seguin J; Perret-Liaudet A; Desestret V; Vighetto A; Bonnefoy M
    Rev Med Interne; 2008 Oct; 29(10):785-93. PubMed ID: 18584921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease.
    Rahmadi A; Steiner N; Münch G
    Clin Chem Lab Med; 2011 Mar; 49(3):385-91. PubMed ID: 21275816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.